Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger



23andMe, a genetic testing start-up that pioneered personalized medicine as a consumer business, trades under ticker “ME” in a deal with Richard Branson’s SPAC.



Source link

Comments